RE:RE:RE:RE:RE:RE:RE:RE:RE:New research from CormarkI'm always open to new ideas. DCM looks cheap, and I guess has some similarities to SXP.
Recent results have been good, Q3 revenue was up 11%, but SXP had revenue up 24%. Balance sheet looks ok. I think you are right about it trading under 5x.
It is very small, only $58 million market cap (SXP at $180 million). This means liquidity is tougher too. As I type this, there hasn't been a single share of DCM trade today.